186 related articles for article (PubMed ID: 32183609)
1. Patient Report of Recurrent and Persistent Thyroid Cancer.
Papaleontiou M; Evron JM; Esfandiari NH; Reyes-Gastelum D; Ward KC; Hamilton AS; Worden F; Haymart MR
Thyroid; 2020 Sep; 30(9):1297-1305. PubMed ID: 32183609
[No Abstract] [Full Text] [Related]
2. Disparities in risk perception of thyroid cancer recurrence and death.
Chen DW; Reyes-Gastelum D; Wallner LP; Papaleontiou M; Hamilton AS; Ward KC; Hawley ST; Zikmund-Fisher BJ; Haymart MR
Cancer; 2020 Apr; 126(7):1512-1521. PubMed ID: 31869452
[TBL] [Abstract][Full Text] [Related]
3. Worry in Thyroid Cancer Survivors with a Favorable Prognosis.
Papaleontiou M; Reyes-Gastelum D; Gay BL; Ward KC; Hamilton AS; Hawley ST; Haymart MR
Thyroid; 2019 Aug; 29(8):1080-1088. PubMed ID: 31232194
[No Abstract] [Full Text] [Related]
4. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
5. Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance.
Evron JM; Reyes-Gastelum D; Banerjee M; Scherer LD; Wallner LP; Hamilton AS; Ward KC; Hawley ST; Zikmund-Fisher BJ; Haymart MR
J Clin Oncol; 2019 Nov; 37(32):3042-3049. PubMed ID: 31573822
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.
Esfandiari NH; Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
J Clin Endocrinol Metab; 2019 Dec; 104(12):6060-6068. PubMed ID: 31415089
[TBL] [Abstract][Full Text] [Related]
7. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
Wallner LP; Reyes-Gastelum D; Hamilton AS; Ward KC; Hawley ST; Haymart MR
J Clin Oncol; 2019 Aug; 37(24):2152-2161. PubMed ID: 31283406
[TBL] [Abstract][Full Text] [Related]
8. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR
Surgery; 2020 Jan; 167(1):102-109. PubMed ID: 31582311
[TBL] [Abstract][Full Text] [Related]
9. Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.
Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
Ann Surg; 2022 Jul; 276(1):e40-e47. PubMed ID: 33074908
[TBL] [Abstract][Full Text] [Related]
10. Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes.
Sapuppo G; Tavarelli M; Belfiore A; Vigneri R; Pellegriti G
J Clin Endocrinol Metab; 2019 Feb; 104(2):258-265. PubMed ID: 30165559
[TBL] [Abstract][Full Text] [Related]
11. Primary Care Provider Involvement in Thyroid Cancer Survivorship Care.
Radhakrishnan A; Reyes-Gastelum D; Gay B; Hawley ST; Hamilton AS; Ward KC; Wallner LP; Haymart MR
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3300-6. PubMed ID: 32639557
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
[No Abstract] [Full Text] [Related]
13. Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.
Radhakrishnan A; Reyes-Gastelum D; Abrahamse P; Gay B; Hawley ST; Wallner LP; Chen DW; Hamilton AS; Ward KC; Haymart MR
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1096-e1105. PubMed ID: 34718629
[TBL] [Abstract][Full Text] [Related]
14. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
[TBL] [Abstract][Full Text] [Related]
15. Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden.
Hedman C; Djärv T; Strang P; Lundgren CI
Acta Oncol; 2016; 55(3):365-9. PubMed ID: 26541091
[TBL] [Abstract][Full Text] [Related]
16. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.
Nickel B; Tan T; Cvejic E; Baade P; McLeod DSA; Pandeya N; Youl P; McCaffery K; Jordan S
JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):231-238. PubMed ID: 30653212
[TBL] [Abstract][Full Text] [Related]
17. High rate of persistent/recurrent disease among patients with differentiated thyroid cancer in Saudi Arabia: factors affecting nonremission.
Raef H; Alfadhli E; Al-Hajjaj A; Malabu UH; Al-Sobhi S; Rifai A; Al Nuaim A
Ann Saudi Med; 2008; 28(4):277-81. PubMed ID: 18596397
[TBL] [Abstract][Full Text] [Related]
18. Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence.
Kovatch KJ; Reyes-Gastelum D; Sipos JA; Caoili EM; Hamilton AS; Ward KC; Haymart MR
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 147(2):166-72. PubMed ID: 33355635
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
20. Treatment-Free Survival in Patients With Differentiated Thyroid Cancer.
Banerjee M; Reyes-Gastelum D; Haymart MR
J Clin Endocrinol Metab; 2018 Jul; 103(7):2720-2727. PubMed ID: 29788217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
